SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?


To: SusieQ1065 who wrote (10331)8/10/2001 8:43:57 AM
From: keithcray  Read Replies (1) | Respond to of 208838
 
Yep, Goldman nailed the coffin shut on software this morning.

Mebbe some kind of capitulatory move in these today, though.



To: SusieQ1065 who wrote (10331)8/10/2001 8:45:56 AM
From: DebtBomb  Read Replies (2) | Respond to of 208838
 
I can't believe how low the pre-market volume is, I'm looking at some big stocks that only have 500, 1000, 3000, shares traded on island, it's like there's no sellers left, but it's also like there's no buyers.



To: SusieQ1065 who wrote (10331)8/10/2001 8:58:29 AM
From: keithcray  Read Replies (1) | Respond to of 208838
 
Watching ADRX up 7 points.

08:07 ET Andrx (ADRX) 60.20: Rallies 8.8% in pre-market on news that AstraZeneca (AZN) does not plan to list two aaiPharma's (AAII) patents in the FDA Orange Book. By listing the patents, AZN could have delayed FDA approval of the Andrx's generic version of Prilosec.